US Stock MarketDetailed Quotes

ELTX Elicio Therapeutics

Watchlist
  • 5.620
  • +0.480+9.34%
Close Jan 3 16:00 ET
60.65MMarket Cap-1.29P/E (TTM)

Elicio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Elicio Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Elicio Therapeutics Earnings Reports

  • Elicio Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 16:17 ET

  • Elicio Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13, 2024 17:02 ET

  • Elicio Therapeutics | 10-Q: Quarterly report

    May 15, 2024 16:48 ET

  • Elicio Therapeutics | 10-K/A: Annual report (Amendment)

    Apr 29, 2024 07:02 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DexCom
    DXCM
    +3.27%
    Collegium Pharmaceutical
    COLL
    +3.07%
    Lantheus
    LNTH
    +2.71%
    Cars.com
    CARS
    +1.72%
    YETI Holdings
    YETI
    +1.60%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data